Table 3.
Demographic and clinical characteristics of the two groups selected during enrollment of Italian volunteers of the retrospective study in the PainOMICS project
| Characteristics of patients | Case (no benefit with side effects) | Control (benefit without side effects) | Total cohort | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | M | SD | % | n | M | SD | % | n | M | SD | % | ||
| Age | 68.7 | 13.1 | 66.5 | 14.5 | 6.8 | 14.3 | |||||||
| Sex | Male | 7 | 28.13 | 59 | 34.9 | 66 | 35.1 | ||||||
| Female | 20 | 71.9 | 110 | 65.1 | 130 | 64.9 | |||||||
| Weight (kg) | 73.1 | 14.6 | 74.7 | 14.4 | 74.5 | 14.4 | |||||||
| Height (cm) | 163.5 | 8.5 | 165.9 | 8.9 | 165.5 | 8.8 | |||||||
| BMI | 27.3 | 4.7 | 27.1 | 5 | 27.2 | 4.9 | |||||||
| Smoker | 8 | 29.6 | 46 | 27.2 | 54 | 27.6 | |||||||
| Pain generator | Radiculopathy | 8 | 33.3 | 69 | 41.1 | 77 | 40 | ||||||
| Stenosis | 4 | 13.3 | 11 | 6.3 | 15 | 7.3 | |||||||
| Sacroiliac joint | 4 | 13.3 | 14 | 8.4 | 18 | 9.1 | |||||||
| Widespread Degeneration | 6 | 23.3 | 31 | 18.4 | 37 | 19.1 | |||||||
| Zygapophyseal/facet joint | 5 | 16.7 | 44 | 25.8 | 49 | 24.5 | |||||||
| Pathophysiology of pain | Spinal stenosis | 12.9 | 4.7 | 5.9 | |||||||||
| Facet joint pain | 16.1 | 25.8 | 24.4 | ||||||||||
| Sacroiliac joint pain | 12.9 | 8.9 | 9.5 | ||||||||||
| Radicular pain | 35.5 | 42.6 | 41.6 | ||||||||||
| Widespread pain | 22.6 | 17.9 | 18.6 | ||||||||||
| Total score of pain detected | 12.6 | 6.2 | 12.6 | 7.2 | 12.6 | 7 | |||||||
| Opioid | Codeine | 10 | 37 | 87 | 51.5 | 97 | 49.5 | ||||||
| Oxycodone | 17 | 63 | 82 | 48.5 | 99 | 50.5 | |||||||
| Other drugs | No | 87.1 | 82.8 | 83.4 | |||||||||
| Yes | 12.9 | 17.2 | 16.6 | ||||||||||
Abbreviation: BMI, body mass index.